M. Toftager

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles

M. Toftager, Jeanette Bogstad, Thue Bryndorf et al. · Human Reproduction · 2016 · 178 citations · Full text

Medicine, Endocrinology, Gynecology +14

Cumulative live birth rates after one ART cycle including all subsequent frozen–thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols

M. Toftager, J Wulff Bogstad, Kristine Løssl et al. · Human Reproduction · 2017 · 134 citations · Full text

Veterinary Medicine, Gynecology, Fertility +12

Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols

M. Toftager, Randi Sylvest, Lone Schmidt et al. · Fertility and Sterility · 2017 · 38 citations · Full text

Medicine, Endocrinology, Gynecology +15

Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology

M. Toftager, Liv V. Hjordt, P.S. Jensen et al. · Human Reproduction · 2014 · 18 citations · Full text

Medicine, Endocrinology, Psychology +16